TS Brandco Holdings

TherapeuticsMD is a women's healthcare company focused on developing and commercializing products for family planning, reproductive health, and menopause management. The company's portfolio includes three FDA-approved products: ANNOVERA, a long-acting contraceptive vaginal ring; IMVEXXY, a low-dose estrogen therapy for vulvar and vaginal atrophy; and BIJUVA, a bio-identical hormone therapy. In early 2023, the company transitioned to a royalty-based business model by licensing its entire commercial portfolio to Mayne Pharma. TS Brandco Holdings, LLC is the subsidiary entity that holds the intellectual property and brand assets for these products, originally established as part of a financing arrangement with Sixth Street. The company is headquartered in Boca Raton, Florida, and currently operates as a holding company for its royalty interests.